Australia markets close in 2 hours 5 minutes

Cyclopharm Limited (CYC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.78000.0000 (0.00%)
As of 10:02AM AEST. Market open.

Cyclopharm Limited

1 The Crescent
Unit 4
Kingsgrove, NSW 2208
Australia
61 2 9541 0411
https://www.cyclopharm.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 87

Key executives

NameTitlePayExercisedYear born
Mr. James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDMCEO, MD, Company Secretary & Director624.04kN/A1965
Mr. Mathew FaragChief Operating Officer432.68kN/AN/A
Mr. Graham N. PhillipsFinance Manager152.02kN/AN/A
Ms. Sally-Ann CorneliusHead of SalesN/AN/AN/A
Ms. Niamh McAreeHead of Quality and RegulatoryN/AN/AN/A
Mr. Chris QuinnHead of ServiceN/AN/AN/A
Ms. Sui Ling CheahFinancial Controller63.73kN/A1970
Mr. Lynn McLauchlinGeneral Manager of Canada172kN/AN/A
Mr. Gary T. SomervilleQuality & Regulatory Manager151.96kN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.

Corporate governance

Cyclopharm Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.